Watch the replays of our conferences:
March 18th - Webinar : European Biotech Valuation
- Sep 21, 7:00 PM – 10:00 PM GMT+2Paris, 24 Bd Pasteur, 75015 Paris, FranceA major part of the IND process is the regulatory aspect: what are the critical issues to anticipate? Who should you talk with, and how to best plan your regulatory strategy? In the end, careful planification of these regulatory considerations can save a company a lot of time and money.